Expression and correlation of Bmi-1, AEG-1 and FHIT in bladder transitional cell carcinoma | Zendy

Wei Su | Zendy; Chengwen Li | Zendy; Xin Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Expression and correlation of Bmi-1, AEG-1 and FHIT in bladder transitional cell carcinoma

Author(s) -

Wei Su,

Chengwen Li,

Xin Li

Publication year - 2020

Publication title -

translational cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.254

H-Index - 30

eISSN - 2219-6803

pISSN - 2218-676X

DOI - 10.21037/tcr.2020.01.13

Subject(s) - fhit , immunohistochemistry , pathological , western blot , pathology , bladder cancer , lymph node , medicine , biology , cancer , gene , carcinogenesis , tumor suppressor gene , biochemistry

As one of the most common tumors in the urogenital system, bladder carcinoma (BC) is the second leading cause of death (1). To calculate mortality, the number of patients with BC is estimated to be more than 160,000 every year. For the past 20 years, the incidence of BC has been rising, which ranks the 7th in male and the 17th in female worldwide (2). Bladder transitional cell carcinoma (BTCC) is the most common malignancy in the bladder and accounts for 90% of all malignant bladder tumors (3,4). At present, although the mechanism of occurrence and Original Article

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research